Loading…

Poly(β-amino ester)-based gene delivery systems: From discovery to therapeutic applications

Poly(β-amino ester)s (PβAE) were firstly synthesized in 1983 but only in 2000 these polymers were used for the first time as gene carrier. Thenceforward, due to their excellent gene delivery properties, PβAE were amply explored to afford very effective non-viral vectors. The promising results obtain...

Full description

Saved in:
Bibliographic Details
Published in:Journal of controlled release 2019-09, Vol.310, p.155-187
Main Authors: Cordeiro, Rosemeyre A., Serra, Arménio, Coelho, Jorge F.J., Faneca, Henrique
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Poly(β-amino ester)s (PβAE) were firstly synthesized in 1983 but only in 2000 these polymers were used for the first time as gene carrier. Thenceforward, due to their excellent gene delivery properties, PβAE were amply explored to afford very effective non-viral vectors. The promising results obtained both in vitro and in vivo studies involving different areas, from cancer therapy to tissue engineering area have aroused a broad interest of the scientific community for this family of biodegradable cationic polymers. This review is the first comprehensive and critical overview of the use of PβAEs as gene carrier. The rational design of PβAEs is a major step aiming to achieve high transfection efficiencies. Moreover, it has been demonstrated that often very small changes in the structure of these polymers have an impressive impact on the transfection efficiency. A critical discussion on the structure performance relationships is presented as well as the outlook for next developments involving these polymers. [Display omitted] •Relationship between physicochemical properties of PβAEs and transfection activity•Types of gene delivery systems based on PβAE•Mechanisms involved in the gene delivery process mediated by PβAE-based systems•Potential therapeutic applications of PβAE-based non-viral vectors
ISSN:0168-3659
1873-4995
DOI:10.1016/j.jconrel.2019.08.024